Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 655,977 | 311,355 | 1,020,951 | 728,715 | 428,222 |
| Depreciation Amortization | 109,612 | 53,710 | 216,209 | 161,454 | 106,812 |
| Accounts receivable | -31,436 | 36,417 | -134,278 | -76,755 | -20,269 |
| Other Working Capital | -174,297 | -59,400 | 44,784 | -12,341 | -53,155 |
| Other Operating Activity | 74,305 | -16,544 | 253,594 | 160,073 | 97,505 |
| Operating Cash Flow | $634,161 | $325,538 | $1,401,260 | $961,146 | $559,115 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,028 | 2,778 | -11,765 | -9,442 | -7,305 |
| PPE Investments | -38,484 | -17,840 | -99,460 | -74,579 | -53,388 |
| Net Acquisitions | -670 | N/A | -133,464 | -113,767 | -110,688 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 250 |
| Purchase Sale Intangibles | -4,592 | -1,767 | -15,396 | -13,954 | -12,036 |
| Other Investing Activity | 2,580 | 17,208 | -25,095 | -25,487 | -18,992 |
| Investing Cash Flow | $-34,546 | $2,146 | $-269,784 | $-223,275 | $-190,123 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 105,000 | 105,000 | 105,000 |
| Debt Repayment | -35,000 | -30,000 | -835,000 | -535,000 | -315,000 |
| Common Stock Issued | 35,260 | 8,383 | 53,094 | 25,399 | 20,507 |
| Common Stock Repurchased | -124,991 | -50,005 | -150,011 | -100,007 | -50,007 |
| Dividend Paid | -155,586 | -77,891 | -282,320 | -211,767 | -141,275 |
| Other Financing Activity | -17,978 | -1,244 | -10,050 | -9,629 | -9,315 |
| Financing Cash Flow | $-298,295 | $-150,757 | $-1,119,287 | $-726,004 | $-390,090 |
| Exchange Rate Effect | -17,737 | 11,073 | -1,719 | -1,848 | 3,454 |
| Beginning Cash Position | 238,361 | 238,361 | 227,891 | 227,891 | 227,891 |
| End Cash Position | 521,944 | 426,361 | 238,361 | 237,910 | 210,247 |
| Net Cash Flow | $283,583 | $188,000 | $10,470 | $10,019 | $-17,644 |
| Free Cash Flow | |||||
| Operating Cash Flow | 634,161 | 325,538 | 1,401,260 | 961,146 | 559,115 |
| Capital Expenditure | -38,484 | -17,840 | -99,460 | -74,579 | -53,388 |
| Free Cash Flow | 595,677 | 307,698 | 1,301,800 | 886,567 | 505,727 |